Western Remedies Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 17-11-2024
- Paid Up Capital ₹ 4.00 M
as on 17-11-2024
- Company Age 43 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.52 M
as on 17-11-2024
- Revenue %
(FY 2023)
- Profit -10.07%
(FY 2023)
- Ebitda -10.07%
(FY 2023)
- Net Worth -0.72%
(FY 2023)
- Total Assets -0.02%
(FY 2023)
About Western Remedies
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹2.52 M.
Barota Malhoutra and Suresh Naidu serve as directors at the Company.
- CIN/LLPIN
U24232MP1981PTC001855
- Company No.
001855
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Nov 1981
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Western Remedies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Naidu  | Director | 07-Sep-2015 | Current |
| Barota Malhoutra | Director | 19-Nov-1981 | Current |
Financial Performance of Western Remedies.
Western Remedies Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10.07% decrease in profit. The company's net worth dipped by a decrease of 0.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Western Remedies?
In 2023, Western Remedies had a promoter holding of 80.25% and a public holding of 19.75%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Primella Sanitary Products Private LimitedActive 50 years 3 months
Barota Malhoutra and Suresh Naidu are mutual person
- Airoplast Private LimitedActive 60 years 7 months
Barota Malhoutra and Suresh Naidu are mutual person
- Jkm Holdings Private LimitedActive 61 years 7 months
Barota Malhoutra and Suresh Naidu are mutual person
- Conbar India Private LimitedActive 31 years 10 months
Barota Malhoutra and Suresh Naidu are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Indore Creation Date: 15 Jul 1988 | ₹0.20 M | Open |
The M. P. Financial Corporation Creation Date: 25 Sep 1984 | ₹0.57 M | Open |
M. P. Financial Corporation Creation Date: 18 May 1984 | ₹1.75 M | Open |
How Many Employees Work at Western Remedies?
Unlock and access historical data on people associated with Western Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Western Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Western Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
